Pre-erythrocytic malaria vaccines: towards greater efficacy. - Wikidata - awgldk - TriplyDB

Pre-erythrocytic malaria vaccines: towards greater efficacy.

Pre-erythrocytic malaria vaccines: towards greater efficacy.

http://www.wikidata.org/entity/Q36403400

about

Malaria vaccine: a future hope to curtail the global malaria burden Searching for the human genetic factors standing in the way of universally effective vaccines Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates 4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques Malaria: progress, perils, and prospects for eradication Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.Sterile protection against malaria is independent of immune responses to the circumsporozoite protein.Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.Memory CD8+ T cell differentiation Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy Anti-malarial market and policy surveys in sub-Saharan Africa The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.Plasmodium sporozoites trickle out of the injection site CD8+ T effector memory cells protect against liver-stage malaria.Host pathogen protein interactions predicted by comparative modeling.Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.A clash to conquer: the malaria parasite liver infection.RTS,S/AS02A for malaria.Experience and challenges from clinical trials with malaria vaccines in Africa Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity.Effective induction of high-titer antibodies by viral vector vaccines.Viral vector vaccines make memory T cells against malaria.IFNγ Responses to Pre-erythrocytic and Blood-stage Malaria Antigens Exhibit Differential Associations With Past Exposure and Subsequent Protection.Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.Malaria vaccines and their potential role in the elimination of malaria.What can transgenic parasites tell us about the development of Plasmodium-specific immune responses?AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5 Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria Various carrier system(s)- mediated genetic vaccination strategies against malaria.Synergism from combinations of infection-blocking malaria vaccines

P2860

Q26996425-A68DB077-07AC-4A4A-A448-D93EFEEB0526 Q27007034-248CACE5-8953-4104-B191-9467DF5D4457 Q27306708-624492EC-D6D6-45ED-93AE-A443628C7867 Q27314155-525532A8-CCF8-4F4F-9F14-FECCADA2E561 Q27485634-521118E1-30FF-48B0-9C61-3BA6CDF94EA8 Q28742762-99AB244C-4A56-49F5-A99B-17CF0B05D306 Q30991737-A86E5684-8688-4FAE-8AF2-121B86A12986 Q33303670-4D1EA958-E397-4FA5-AEE9-F393AE3341CE Q33312392-78F05B59-A978-406B-8667-A25BA951BDC9 Q33320536-29E905EB-45B8-473C-9BA8-A857C1463F58 Q33400526-426EFA44-C980-45DB-9A02-14DAFE1DCD93 Q33464933-EAB86D88-6CBE-49ED-9078-35D6360DA853 Q33512110-05701DD0-1028-4A5B-92FE-96CD52284105 Q33720379-398D0FB3-D104-48E9-BAF9-074D49B287A5 Q33779750-47AD6FCE-0763-4386-BD39-0E3531FA3E43 Q34025527-D252E0FB-B08E-4C23-B199-ABB9CE37F78E Q34407223-CD70E06C-C49D-4B7A-AC49-378E8C7FC938 Q34684347-67F92911-29FF-4FE0-89B5-8EE02FFCDF78 Q34781353-FCBB45DA-2155-414A-AE2E-2DD688DFB23D Q35683634-2E0C7259-ECBC-4EC1-BCA8-FE542F7848EA Q35751946-E8453BAE-6533-46D5-8DF8-297EC67A853D Q35783390-3A5CC3EE-6F96-48C8-9F26-B3A71E3097DD Q36055733-93A89107-D1D1-4C57-93CF-C96D115B0E12 Q36420301-5E06CFD9-BDD0-4D44-B823-670303B4A9B5 Q36483682-EAD2D029-4D5D-4923-A8EA-38773E3C7CA6 Q36571340-825B46F2-FA75-4E6B-8940-99B103CED94A Q36639087-BF163BB2-782D-4C6E-ACBA-2C1246F6715B Q36689000-120B80D6-DD2E-4E60-BB30-4D016115EBE9 Q36690983-175E3F46-5FA1-4F9E-8414-CE8A5CF79877 Q36728808-E8735B82-6A74-4BB8-B626-84A2BE8DCEE3 Q36770379-3E071EC4-9469-4E76-9486-C1C0830BA2E7 Q36802741-FA818EF8-993F-4718-AF7E-02C4B5527820 Q36812832-F8D7F261-60F2-4EC3-864B-E62B21C0B7F5 Q36893651-AB023E18-8D67-41DC-A9DE-21D3C623F229 Q37018637-5C304677-BE1D-45B4-86EC-E0BA8211F247 Q37103943-E9E3CED7-5435-48B0-9791-4599AE0790B6 Q37144187-4FFB1483-B25E-465E-9D75-A369EEAFD902 Q37146236-3D035F95-FC09-4DCF-B02E-25A20D415629 Q37150329-EF5C25DD-0FFB-4FD5-8D77-0B196FB5C0C4 Q37151822-74AC975F-A4FF-4470-8853-E5D28B6CA835

P2860

Pre-erythrocytic malaria vaccines: towards greater efficacy.

http://www.wikidata.org/entity/Q36403400

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@ast

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@en

type

label

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@ast

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@en

prefLabel

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@ast

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@en

P1433

Q36403400-C53A681D-8823-4D96-9443-F711BDD0AD44

P1476

Q36403400-3663430B-0D49-4C78-BBF1-131CC1EA351C

P2860

Q36403400-003539F6-9C4A-438E-81DA-4281F1D2D1FE

Q36403400-03DFAE50-3CBF-4D5A-B283-B3BFC5261B63

Q36403400-048497F2-AA27-42F7-A666-9E41BD680BA4

Q36403400-05CF0B6D-8594-4B5C-9ACF-37EA0A3CBE06

Q36403400-08066E5A-DDEC-496D-BDCB-F113A2548AEF

Q36403400-0B2EA66D-4368-47A4-8C96-7032C21771C2

Q36403400-0CB6352F-F6B6-4C38-8045-AFBFC0587581

Q36403400-0D426C89-DA95-490D-829F-F63F4BD5B518

Q36403400-120754CA-9FA4-4812-935A-7340FBE046A5

Q36403400-120A7F7B-5EBE-42FE-8780-6CCA846C2B53

P304

Q36403400-A360469C-57A8-4B77-A9FA-B1995C39CB4E

P31

Q36403400-7620CBDC-F977-47DE-B97B-CD0568CF1843

P356

Q36403400-A243B885-0DF2-405D-AF8F-566B18CC388C

P433

Q36403400-EEB73284-17CD-407B-AAE8-E137B0B13A7B

P478

Q36403400-0CA6FCE7-01C1-44AA-B8D9-AB832D816365

P50

Q36403400-23503597-62E9-4C63-B25B-FA429CE49286

P577

Q36403400-2982B7D0-9EDF-4D38-93BA-5D4C35A59F18

P698

Q36403400-D158F63A-94AD-4D89-91E6-A683A25DCB73

P921

Q36403400-1227112D-E9BC-4CA6-9562-7E1175069F01

P356

P1433

Nature Reviews Immunology

P1476

Pre-erythrocytic malaria vaccines: towards greater efficacy.

@en

P2860

Genome sequence of the human malaria parasite Plasmodium falciparum

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

The global distribution of clinical episodes of Plasmodium falciparum malaria

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei

Common west African HLA antigens are associated with protection from severe malaria

A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses

Central memory and effector memory T cell subsets: function, generation, and maintenance

P304

21-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRI1746

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Adrian V. S. Hill

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16493425

http://www.w3.org/2001/XMLSchema#string

P921